Update on the treatment of depression during pregnancy

Therapy

Volumn 3, Issue 1, 2006, Pages 153-161

  Born, Leslie ^a,b   Zinga, Dawn ^c   Phillips, Shauna Dae ^b,d  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b Women's Health Concerns Clinic   (Canada)

^c BROCK UNIVERSITY   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

Author keywords

Alternative medicine; Complimentary medicine; Depression; Dysthymia; Pharmacologic therapy; Postpartum depression; Pregnancy; Psychoeducation; Psychotherapy

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLONAZEPAM; DESVENLAFAXINE; DRUG METABOLITE; FLUOXETINE; FLUVOXAMINE; HYPNOTIC AGENT; LORAZEPAM; NEFAZODONE; NORADRENALIN UPTAKE INHIBITOR; NORCITALOPRAM; NORFLUOXETINE; NORSERTRALINE; PAROXETINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ACUPUNCTURE; ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONGENITAL MALFORMATION; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSTHYMIA; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR DEPRESSION; MASSAGE; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PATIENT EDUCATION; PHOTOTHERAPY; PREGNANCY; PRENATAL CARE; PREVALENCE; PSYCHIATRIC TREATMENT; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; PUERPERAL DEPRESSION; REVIEW; RISK BENEFIT ANALYSIS; SLEEP DEPRIVATION; TERATOGENICITY; UNSPECIFIED SIDE EFFECT;

EID: 33646188735     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.1586/14750708.3.1.153     Document Type: Review

References (80)

1. O'Hara MW, Zekoski EM, Philipps LH, Wright EJ. Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J. Abnorm. Psychol. 99(1), 3-15 (1990).
2. Felice E, Saliba J, Grech V, Cox J. Prevalence rates and psychosocial characteristics associated with depression in pregnancy and postpartum in Maltese women. J. Affect. Disord. 82(2), 297-301 (2004).
3. Josefsson A, Berg G. Nordin C, Sydsjo G. Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet. Gynecol. Scand. 80(3), 251-255 (2001).
4. Johanson R, Chapman G, Murray D, Johnson I, Cox J. The North Staffordshire Maternity Hospital prospective study of pregnancy-associated depression. J. Psychosom. Obstet. Gynaecol. 21, 93-97 (2000).
5. Henshaw C, Foreman D, Cox J. Postnatal blues: a risk factor for postnatal depression. J. Psychosom. Obstet. Gynaecol. 25(3-4), 267-272 (2004).
6. Georgiopoulos AM, Bryan TL, Wollen P, Yawn BP. Routine screening for postpartum depression. J. Fam. Pract. 50(2), 117-122 (2001).
7. Brockington IF. A Portfolio of Postpartum Disorders. In: Motherhood and Mental Health. Oxford University Press, Oxford, UK, 135-199 (1996).
8. Kitamura T, Shima S, Sugawara M, Toda MA. Psychological and social correlates of the onset of affective disorders among pregnant women. Psychol. Med. 23(4), 967-975 (1993).
9. Kumar R, Robson KM. A prospective study of emotional disorders in childbearing women. Br. J. Psychiatry 144, 35-47 (1984).
10. Heron J, O'Connor TG, Evans J, Golding J, Glover V. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J. Affect. Disord. 80(1), 65-73 (2004).
11. Fergusson DM, Horwood LJ, Thorpe K. Changes in depression during and following pregnancy. ALSPAC Study Team. Study of Pregnancy and Children. Paediatr. Perinat. Epidemiol. 10(3), 279-293 (1996).
12. Rubertsson C, Wickberg B, Gustavsson P, Radestad I. Depressive symptoms in early pregnancy, two months and one year postpartum - prevalence and psychosocial risk factors in a national Swedish sample. Arch. Women Ment. Health 8 (2), 97-104 (2005).
13. Patel V, Rodrigues M, DeSouza N. Gender, poverty, and postnatal depression: a study of mothers in Goa, India. Am. J. Psychiatry 159, 43-47 (2002).
14. Alati R, Lawlor DA, Najman JM, Williams GM, Bor W, O'Callaghan M. Is there really a 'J-shaped' curve in the association between alcohol consumption and symptoms of depression and anxiety? Findings from the Mater University study of pregnancy and its outcomes. Addiction 100(5), 643-651 (2005).
15. Pajulo M, Savonlahti E, Sourander A, Helenius H, Piha J. Antenatal depression, substance dependency and social support. J. Affect Disord. 65(1), 9-17 (2001).
16. Flynn HA, Marcus SM, Barry KL, Blow FC. Rates and correlates of alcohol use among pregnant women in obstetrics clinics. Alcohol Clin. Exp. Res. 27(1), 81-87 (2003).
17. Hayes BA, Muller R. Prenatal depression: a randomized controlled trial in the emotional health of primiparous women. Res. Theory. Nurs. Pract. 18(2-3), 165-183 (2004).
18. Yonkers KA, Ramin SM, Rush AJ et al. Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am. J. Psychiatry 158 (11), 1856-1863 (2001).
19. O'Hara MW, Swain AM. Rates and risk of postpartum depression: a meta-analysis. Int. Rev. Psychiatry 8, 37-54 (1996).
20. Gotlib IH, Whiffen VE, Wallace PM, Mount JH. Prospective investigation of postpartum depression: factors involved in onset and recovery. J. Abnorm. Psychol. 100, 122-132 (1991).
21. American Psychiatric Association. Dysthymic disorder. In: Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, DC, USA, 376-381 (2000).
22. Orr ST, James SA, Blackmore Prince C. Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am. J. Epidemiol. 156 (9), 797-802 (2002).
23. Drewett R, Blair P, Emmett P, Emond A, the ALSPAC study team. Failure to thrive in the term and preterm infants of mothers depressed in the postnatal period: a population-based birth cohort study. J. Child Psychol Psychiatry 45(2), 359-366 (2004).
24. Rahman A, Iqbal Z, Bunn J, Lovel H, Harrington R. Impact of maternal depression on infant nutritional status and illness: a cohort study. Arch. Gen. Psychiatry 61(9), 946-952 (2004).
25. Lundy B L, Jones NA, Field T et al. Prenatal depression effects on neonates. Infant Behav. Dev. 22, 119-129 (1999).
26. Murray L, Sinclair D, Cooper P, Ducournau P, Turner P, Stein A. The socioemotional development of 5-year old children of postnatally depression mothers. J. Child Psychol Psychiatry 40, 1259-1271 (1999).
27. Huot RL, Brennan PA, Stowe ZN, Plotsky PM, Walker EF. Negative affect in offspring of depressed mothers is predicted by infant cortisol levels at 6 months and maternal depression during pregnancy, but not postpartum. Ann. NY Acad. Sci. 1032, 234-236 (2004).
28. Newport DJ, Stowe ZN, Nemeroff CB. Parental depression: animal models of an adverse life event. Am. J. Psychiatry 159(8), 1265-1283 (2002).
29. Wisner KL, Zarin DA, Holmboe ES et al. Risk-benefit decision making for treatment of depression during pregnancy. Am. J. Psychiatry 157(12), 1933-1940 (2000).
30. Bonari L, Pinto N, Ahn E, Einarson A. Steiner M, Koren G. Perinatal risks of untreated depression during pregnancy. Can. J. Psychiatry, 19(11), 726-735 (2000).
31. Altshuler LL, Cohen LS, Moline ML, Kahn DA, Carpenter D, Docherty JP. Expert consensus panel for depression in women. The Expert Consensus Guideline Series. Treatment of depression in women. Postgrad. Med. 1-107 (2001).
32. Hendrick V, Altshuler L. Management of major depression during pregnancy. Am. J. Psychiatry 159, 1667-1673 2002.
33. Koren G, Matsui D, Einarson A, Knoppert D, Steiner M. Is maternal use of selective serotonin re-uptake inhibitors in the third trimester of pregnancy harmful to neonates? CMAJ 172(11), 1457-1459 (2005).
34. Miller LJ. Use of electroconvulsive therapy during pregnancy. Hosp. Community Psychiatry 45, 444-450 (1994).
35. Oren DA, Wisner KL, Spinelli M et al. An open trial of morning light therapy for treatment of antepartum depression. Am. J. Psychiatry 159(4), 666-669 (2002).
36. Epperson CN, Terman M, Terman JS, Hanusa BH, Oren DA, Peindl K et al. Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J. Clin. Psychiatry 65(3), 421-425 (2004).
37. Field T, Diego MA, Hernandez-Reif M, Schanberg S, Kuhn C. Massage therapy effects on depressed pregnant women. J. Psychosom. Obstet. Gynecol. 25, 115-122 (2004).
38. Manber R, Schnyer RN, Allen JJ, Rush AJ, Blasey CM. Acupuncture: a promising treatment for depression during pregnancy. J. Affect. Disord. 83(1), 89-95 (2004).
39. Parry BL, Curran ML, Stuenkel CA et al. Can critically timed sleep deprivation be useful in pregnancy and postpartum depressions? J. Affect. Disord. 60(3), 201-212 (2000).
40. Giedke H, Schwarzler F. Therapeutic use of sleep deprivation in depression. Sleep Med. Rev. 6(5), 361-377 (2002).
41. Hillier CA, Slade P. The impact of antenatal classes on knowledge, anxiety and confidence in primiparous women. J. Reprod. Infant Psychol. 7, 3-13 (1989).
42. Webster J, Pritchard MA, Creedy D, East C. A simplified predictive index for the detection of women at risk for postnatal depression. Birth 30(2), 101-108 (2003).
43. Brugha TS. Wheatley NA, Taub NA et al. Pragmatic randomized trial of antenatal intervention to prevent postnatal depression by reducing psychosocial risk factors. Psychol. Med. 30, 1273-1281 (2002).
44. Hayes BA, Muller R, Bradley, BS. Perinatal depression: a randomized controlled trial of an antenatal education intervention for primiparas. Birth 28(1), 28-35 (2001).
45. Elliott SA, Leverton TJ, Sanjack M et al. Promoting mental health after childbirth: a controlled trial of postnatal depression. Br. J. Clin. Psychol. 39(Suppl.3), 223-241 (2000).
46. Buist A, Westly D, Hill C. Antenatal prevention of postnatal depression. Arch. Women Ment. Health 1, 167-173 (1999).
47. Stamp GE, Williams AS, Crowther CA. Evaluation of an antenatal and postnatal support to overcome postnatal depression: a randomized controlled trial. Birth 22(3), 138-143 (1995).
48. Barlow J, Coren E. Stewart-Brown S. Meta-analysis of parenting programmes in improving maternal psychosocial health. Br. J. Gen. Prac. 52, 223-233 (2002).
49. de Mello MF, de Jesus MJ, Bacaltchuk J, Verdeli H, Neugebauer R. A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders. Eur. Arch. Psychiatry Clin. Neurosci. 255(2), 75-82 (2005).
50. Spinelli MG. Interpersonal psychotherapy for depressed antepartum women: a pilot study. Am. J. Psychiatry 154(7), 1028-1030 (1997).
51. Spinelli MA. Interpersonal psychotherapy for antepartum depressed women. In: Management of psychiatric disorders in pregnancy: management of psychiatric disorders in pregnancy. Yonkers K, Little B (Eds). Oxford University Press, London, UK, 105-121 (2001).
52. Swartz HA, Markowitz JC, Spinelli MG. Interpersonal psychotherapy of a depressed, pregnant HIV-positive woman. J. Psychother. Pract. Res. 6(2), 165-178 (1997).
53. Spinelli MG, Endicott J. Controlled clinical trial of interpersonal psychotherapy versus parenting education program for depressed pregnant women. Am. J. Psychiatry 160(3), 555-562 (2003).
54. Zlotnick C, Johnston SJ, Miller IW, Pearlstein T, Howard M. Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapy-oriented group intervention. Am. J. Psychiatry 158(4), 638-640 (2001).
55. Grote NK, Bledsoe SE, Schwartz HA, Frank E. Feasibility of providing culturally relevant, brief interpersonal psychotherapy for antenatal depression in an obstetrics clinic: a pilot study Res. Social Work Pract. 14(6), 397-407 (2004).
56. Hofecker-Fallahpour M, Zinkernagel-Burri CH, Stockli B, Wusten G, Stieglitz RD, Riecher-Rossler A. Group therapy for depression during early motherhood: first results of a pilot study. Nervenarzt 74(9), 767-774 (2003).
57. Tarabusi M, Volpe A, Facchinetti F. Psychological group support attenuates distress of waiting in couples scheduled for assisted reproduction. J. Psychosom. Obstet. Gynecol. 25, 273-279 (2004).
58. Appleby L, Hirst E, Marshall S et al. The treatment of postnatal depression by health visitors: impact of brief training on skills and clinical practice. J. Affect. Disord. 77, 261-266 (2003).
59. Zayas H, McKee MD. Jankowski KRB. Adapting psychosocial intervention research to urban primary care environments: a case example. Ann. Fam. Med. 2 (5), 504-508 (2004).
60. Carter FA, Carter JD, Luty SE, Wilson DA, Frampton CM, Joyce PR. Screening and treatment for depression during pregnancy: a cautionary note. Aust. NZ J. Psychiatry 39(4), 255-61 (2005).
61. Cunningham M, Zayas LH. Reducing depression in pregnancy: designing multimodal interventions. Social Work 47(2), 114-123 (2002).
62. Szigethy EM, Ruiz P. Depression among pregnant adolescents: an integrated treatment approach. Am. J. Psychiatry 158(1), 22-27 (2001).
63. Petersen T, Dording C, Neault NB et al. A survey of prescribing practices in the treatment of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 26(1), 177-187 (2002).
64. Kornstein SG, Kirkwood CK. Antidepressant Drugs. In: Handbook of Female Psychopharmacology. Steiner M. Koren G (Eds), Martin Dunitz, London, UK, 1-17 (2003).
65. Altshuler LL, Cohen LS, Moline ML et al. Treatment of depression in women: a summary of the expert consensus guidelines. J. Pychiatr. Pract. 7(3), 185-208 (2001).
66. Cohen LS, Nonacs R, Viguera AC, Reminick A. Diagnosis and treatment of depression during pregnancy. CNS Spectr. 9(3), 209-216 (2004).
67. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin. Pharmacokinetics 43 (8), 487-514 (2004).
68. Rampono J, Proud S, Hackett LP, Kristensen JH, Ilett KF. A pilot study of newer antidepressant concentrations in cord and maternal serum and possible effects in the neonate. Int. J. Neuropsychopharmacol. 7(3), 329-334, 2004.
69. Hendrick V, Stowe ZN, Altshuler LL, Hwang S, Lee E, Haynes D. Placental passage of antidepressant medications. Am. J. Psychiatry 160(5), 993-996 (2003).
70. Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol. Psychiatry 48(10), 1032-1034 (2000).
71. Koren G. Maternal-Fetal Toxicology: A Cinician's Guide. M Dekker, NY, USA, 2-8 (2001).
72. Einarson TR, Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies. Pharmacoepidemiol. Drug Saf. 14 (12), 823-827 (2005) (Epub ahead of print).
73. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N. Engl. J. Med. 335(14), 1010-1015 (1996).
74. Moses-Kolko EL, Bogen D, Perel J et al. Neonatal signs after late in utero exposure to serotonin re-uptake inhibitors: literature review and implications for clinical applications. JAMA 293(19), 2372-2383 (2005).
75. Sanz EJ, De-las-Cuevas C, Kiuru A, Bate A. Edwards R. Selective serotonin re-uptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365(9458), 482-487 (2005).
76. Field T, Diego M, Hernandez-Reif M et al. Pregnancy anxiety and comorbid depression and anger: effects on the fetus and neonate. Depress. Anxiety 17(3), 140-151 (2003).
77. Einarson A, Schachtschneider AK, Halil R, Bollano E, Koren G. SSRI's and other antidepressant use during pregnancy and potential neonatal adverse effects: impact of a public health advisory and subsequent reports in the news media. BMC Pregnancy Childbirth 5, 11 (2005).
78. Rosenbaume JF, Zajecka J. Clinical management of antidepressant discontinuation. J. Clin. Psychiatry 58 (Suppl. 7), 37-40 (1997).
79. Einarson A, Selby P, Koren G. Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counseling. J. Psychiatry Neurosci. 26(1), 44-48 (2001).
80. Wisner KL, Perel JM, Peindl KS, Hanusa BH. Timing of depression recurrence in the first year after birth. J. Affect. Disord. 78(3), 249-252 (2004).